BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9916669)

  • 1. Atrium and paroxetine-related severe hepatitis.
    Cadranel JF; Di Martino V; Cazier A; Pras V; Bachmeyer C; Olympio P; Gonzenbach A; Mofredj A; Coutarel P; Devergie B; Biour M
    J Clin Gastroenterol; 1999 Jan; 28(1):52-5. PubMed ID: 9916669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hepatotoxicity with jaundice associated with paroxetine.
    Odeh M; Misselevech I; Boss JH; Oliven A
    Am J Gastroenterol; 2001 Aug; 96(8):2494-6. PubMed ID: 11513198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrium-related hepatitis. Report of four cases].
    Horsmans Y; Larrey D; Pessayre D; Rueff B; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1991; 15(8-9):648-52. PubMed ID: 1684328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatotoxicity induced by paroxetine].
    Guzmán Ruiz O; Ramírez Martín del Campo M; Fernandez López I; Romero Gómez M
    Med Clin (Barc); 2005 Mar; 124(10):399. PubMed ID: 15766517
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver injury due to tetrabamate (Atrium): an analysis of 11 cases.
    Dumortier J; Bellemin B; Jacob P; Berger F; Chevallier M; Scoazec JY; Vial T
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):1007-12. PubMed ID: 11007137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hepatitis associated with use of paroxetine.
    Pompili M; Tittoto P; Mascianà R; Gasbarrini G; Rapaccini GL
    Intern Emerg Med; 2008 Sep; 3(3):275-7. PubMed ID: 18265937
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe acute hepatitis caused by Atrium].
    Brocheriou I; Zafrani ES; Mavier P
    Gastroenterol Clin Biol; 1993; 17(4):305-6. PubMed ID: 8339895
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.
    Seedat S; Stein MB
    J Clin Psychiatry; 2004 Feb; 65(2):244-8. PubMed ID: 15003080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrium-induced hepatitis with autoimmune pattern].
    Pariente EA; Mineur D
    Gastroenterol Clin Biol; 1992; 16(5):485-6. PubMed ID: 1526409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute hepatitis associated with microvesicular steatosis induced by Atrium].
    Schneider S; Charles F; Chichmanian RM; Montoya ML; Rampal P
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1064-5. PubMed ID: 8729422
    [No Abstract]   [Full Text] [Related]  

  • 12. The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.
    Jaber BL; Lobon LF; Madias NE
    Am J Med; 2006 Apr; 119(4):e3. PubMed ID: 16564762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 14. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of idiopathic thrombocytopenic purpura associated with paroxetine administration.
    Ono S; Suzuki Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(2):213.e13-5. PubMed ID: 22832136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tetrabamate-induced hepatotoxicity. Report of seven cases and literature review].
    López-Torres E; Lucena MI; Andrade RJ; García Ruiz E; Fernández MC; Peláez G; Soria de la Cruz MJ; Pizarro A
    Gastroenterol Hepatol; 2002 Dec; 25(10):589-93. PubMed ID: 12459120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].
    Llinares-Tello F; Escrivá-Moscardó S; Martínez-Pastor F; Martínez-Mascaraque P
    Med Clin (Barc); 2007 Mar; 128(11):438. PubMed ID: 17394862
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe hepatitis due to Atrium.
    Prescrire Int; 2001 Oct; 10(55):150. PubMed ID: 11824432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association between poor metabolism of mephenytoin and hepatotoxicity caused by Atrium, a fixed combination preparation containing phenobarbital, febarbamate and difebarbamate.
    Horsmans Y; Lannes D; Pessayre D; Larrey D
    J Hepatol; 1994 Dec; 21(6):1075-9. PubMed ID: 7699230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.